Skip to main content
. 2025 Apr 25;12:1570809. doi: 10.3389/fmed.2025.1570809

Table 2.

Demographic data of the retained studies.

Study number First author Sample size OAC group Non-OAC group Mean age (OAC/no-OAC) (years) Sex ratio (M/F) CHA2DS2-VAS score (median) HAS-BLED (median)
1. Abrantes 95 40 55 74.3 ± 8.9/75.8 ± 10.6 1.2/0.96 3.5 ± 7/4 ± 8 4 ± 4/4 ± 6
2. ELDERCARE-AF 80 41 39
3. Komen 2,357 311 2046 79.25 ± 9.35/82.6 ± 54 0.91/0.81 4.33 ± 1.71/4.29 ± 72 2.35 (0.91)/2.48 ± 18
4. Lin 1,566 283 1,283 76.50 ± 21.09/76.20 ± 11.99 0.59/0.58 5.24 ± 3.64/5.23 ± 1.76
5. NASPAF-ICH 30 21 9 78.2 (74–84.7)/78.7 (73.4–83.6) 1.5/1 4/4
6. Nielsen 1752 330 1,035
7. Park 428 254 174 67.9 ± 11.1 /69.1 ± 10.8 0.37/0.28 3.35 ± 1.7/3.16 ± 1.73 3.43 ± 1.13/3.52 ± 1.25
8. Perrault 483 260 423 81.7 ± 5.8/83.6 ± 5.8 0.85/0.89 3.9 ± 1.3/3.9 ± 1.1 2.6 ± 1.1/2.6 ± 1.1
9. Poli 393 162 231 77.1/80.3 0.61/0.39 4/4 3/3
10. Sadighi 98 38 55 74.3 ± 10.5/77.2 ± 10.1 0.65/0.46
11. Sakamot 236 41 195 72 (65–80)/68 (59–78) 0.68/0.67
12. Salman (SoSTART) 203 101 102 79 (74–85)/79 (74–84) 1.58/1.75 4/4 2/2
13. Schreuder (APACHE-AF) 101 50 51 77 (74–83)/79 (72–83) 1.17/1.21 4/4
14. Suda 160 108 52 76 (70–81) /77 (71–84) 0.67/0.72 4 (3–5)/4 (3–5) 3 (2–3)/3 (2–4)
15. Wu 336 186 186 71.0 ± 9.7/71.6 ± 9.5 0.67/0.78 4.1 ± 1.5/4.2 ± 1.5 2.4 ± 0.9/2.5 ± 1.0